Dec 8, 2025 · The correct answer is B - desmopressin does NOT have higher selectivity for V1 receptors; rather, it has markedly diminished V1a (pressor) activity and enhanced selectivity for V2 …

Nov 19, 2025 · Desmopressin offers key advantages over vasopressin, including greater safety, longer duration, and improved antidiuretic selectivity. Explore why desmopressin is the preferred treatment.

Desmopressin (DDAVP) is a synthetic analog of vasopressin (ADH). It is used for: * Central diabetes insipidus (reduces urine output) * Nocturnal enuresis (bedwetting in select children) * Mild hemophilia …

Compare Desmopressin vs Vasopressin head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

Desmopressin (DDAVP) is a synthetic form of vasopressin which comes in oral, inhaled and subcutaneous injectable forms, and is used to treat patients with central diabetes insipidus.

Herein we review the adverse effects of DDAVP and its predecessor, vasopressin, as well as discuss important clinical considerations when using these agents to treat central diabetes insipidus.

1 day ago · The FDA has approved Desmoda (desmopressin acetate) oral solution for managing central diabetes insipidus (CDI) in adults and children. It is a liquid version of a lab‑made form of vasopressin ...